Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022 – 2033
2.3 Market Size & Forecast, By Segmentation, 2022 – 2033
2.3.1 Market Size By Product
2.3.2 Market Size By Application
2.3.3 Market Size By Type
2.3.4 Market Size By Vertical
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Program Performance Metrics
4.1.1 Overview
4.1.2 False-Positive & False-Negative Rates for Key Test Categories
4.1.3 Screening Accuracy, Sensitivity & Specificity Improvements Over Time
4.1.4 Time-to-Result Trends
4.1.5 Recall Rate Statistics
4.2 Operational & Laboratory Efficiency Indicators
4.2.1 Overview
4.2.2 Sample Processing Capacity per Laboratory
4.2.3 Reduction in Laboratory Turnaround Time via Automation, LIMS & NGS Workflows
4.2.4 Instrument Utilization Rate (Mass Spec, PCR, NGS Systems)
4.2.5 Error/Rejection Rates for Dried Blood Spot (DBS) Samples
4.3 Cost & Economic Impact Metrics
4.3.1 Overview
4.3.2 Cost per Newborn Screened
4.3.3 Cost per Condition Detected
4.3.4 Healthcare Savings from Early Detection (ICU Reduction & Long-Term Avoided Costs)
4.3.5 ROI Analysis for Expanding Screening Panels
4.4 Policy & Regulatory Indicators
4.4.1 Overview
4.4.2 Countries Expanding Mandatory Screening Panels
4.4.3 Annual Additions to Recommended Uniform Screening Panels (RUSP)
4.4.4 Government Spending Trends on National Newborn Screening Programs
5. Newborn Screening Market Segmental Analysis & Forecast, By Test Type, 2022 – 2033, Value (USD Billion)
5.1 Introduction
5.2 Dry Blood Spot (DBS) Tests
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2033
5.3 Hearing Screening
5.4 Critical Congenital Heart Disease (CCHD)
5.5 DNA-based / Genetic Screening
6. Newborn Screening Market Segmental Analysis & Forecast, By Technology, 2022 – 2033, Value (USD Billion)
6.1 Introduction
6.2 Tandem Mass Spectrometry (TMS)
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2033
6.3 PCR / Molecular Assays
6.4 Immunoassays (ELISA, FIA, etc.)
6.5 Next-Generation Sequencing (NGS)
7. Newborn Screening Market Segmental Analysis & Forecast, By Product Type, 2022 – 2033, Value (USD Billion)
7.1 Introduction
7.2 Reagents & Assay Kits
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2033
7.3 Instruments / Analyzers
7.4 Hearing Screening Devices
7.5 Consumables & Accessories
8. Newborn Screening Market Segmental Analysis & Forecast, By Application, 2022 – 2033, Value (USD Billion)
8.1 Introduction
8.2 Metabolic Disorders
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2033
8.3 Hormonal Disorders
8.4 Hematological Disorders
8.5 Hearing & CCHD Disorders
8.6 Genetic / Rare Diseases
9. Newborn Screening Market Segmental Analysis & Forecast By Region, 2022 – 2033, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Newborn Screening Market Size & Forecast, By Product, 2022 – 2033
9.2.3 Newborn Screening Market Size & Forecast, By Application, 2022 – 2033
9.2.4 Newborn Screening Market Size & Forecast, By Type, 2022 – 2033
9.2.5 Newborn Screening Market Size & Forecast, By Vertical, 2022 – 2033
9.2.6 Newborn Screening Market Size & Forecast, By Country, 2022 – 2033
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Newborn Screening MarketSize & Forecast, By Product, 2022 – 2033
9.3.3 Newborn Screening MarketSize & Forecast, By Application, 2022 – 2033
9.3.4 Newborn Screening MarketSize & Forecast, By Type, 2022 – 2033
9.3.5 Newborn Screening MarketSize & Forecast, By Vertical, 2022 – 2033
9.3.6 Newborn Screening MarketSize & Forecast, By Country, 2022 – 2033
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Newborn Screening MarketSize & Forecast, By Product, 2022 – 2033
9.4.3 Newborn Screening MarketSize & Forecast, By Application, 2022 – 2033
9.4.4 Newborn Screening MarketSize & Forecast, By Type, 2022 – 2033
9.4.5 Newborn Screening MarketSize & Forecast, By Vertical, 2022 – 2033
9.4.6 Newborn Screening MarketSize & Forecast, By Country, 2022 – 2033
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Newborn Screening MarketSize & Forecast, By Product, 2022 – 2033
9.5.3 Newborn Screening MarketSize & Forecast, By Application, 2022 – 2033
9.5.4 Newborn Screening MarketSize & Forecast, By Type, 2022 – 2033
9.5.5 Newborn Screening MarketSize & Forecast, By Vertical, 2022 – 2033
9.5.6 Newborn Screening MarketSize & Forecast, By Country, 2022 – 2033
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Newborn Screening MarketSize & Forecast, By Product, 2022 – 2033
9.6.3 Newborn Screening MarketSize & Forecast, By Application, 2022 – 2033
9.6.4 Newborn Screening MarketSize & Forecast, By Type, 2022 – 2033
9.6.5 Newborn Screening MarketSize & Forecast, By Vertical, 2022 – 2033
9.6.6 Newborn Screening MarketSize & Forecast, By Country, 2022 – 2033
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2022 – 2033
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 PerkinElmer, Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Bio-Rad Laboratories, Inc.
10.6.3 Agilent Technologies, Inc.
10.6.4 Natus Medical Incorporated
10.6.5 Trivitron Healthcare Pvt Ltd
10.6.6 Danaher Corporation
10.6.7 GE Healthcare
10.6.8 Masimo Corporation
10.6.9 Thermo Fisher Scientific Inc.
10.6.10 AB Sciex LLC
10.6.11 Waters Corporation
10.6.12 Demant A/S
10.6.13 Baebies Inc.
10.6.14 ZenTech S.A.
10.6.15 F. Hoffmann-La Roche AG
10.6.16 LifeCell International Pvt Ltd
10.6.17 MP Biomedicals LLC
10.6.18 Illumina, Inc.
10.6.19 LabCorp (Laboratory Corporation of America Holdings)
10.6.20 Natera, Inc.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
